Management of thyroglobulin positive/whole-body scan negative: is Tg positive/131I therapy useful?

Suppr

超能文献

作者信息

McDougall I R

机构信息

Division of Nuclear Medicine, Stanford University Medical Center, California 94305-5281, USA.

出版信息

J Endocrinol Invest. 2001 Mar;24(3):194-8. doi: 10.1007/BF03343843.

DOI:10.1007/BF03343843

PMID:11314751

Abstract

摘要

相似文献

Management of thyroglobulin positive/whole-body scan negative: is Tg positive/131I therapy useful?

J Endocrinol Invest. 2001 Mar;24(3):194-8. doi: 10.1007/BF03343843.

[Follow-up of patients with differentiated thyroid cancer: determination of serum thyroglobulin in place of routine 131I scintigraphy?].[分化型甲状腺癌患者的随访：用血清甲状腺球蛋白测定替代常规131I闪烁扫描？]

Wien Klin Wochenschr. 1984 May 11;96(10):389-93.

Management of patients with differentiated thyroid cancer who have positive serum thyroglobulin levels and negative radioiodine scans.血清甲状腺球蛋白水平阳性且放射性碘扫描阴性的分化型甲状腺癌患者的管理。

Thyroid. 1994 Winter;4(4):501-5. doi: 10.1089/thy.1994.4.501.

131I treatment of 131I negative whole body scan, and positive thyroglobulin in differentiated thyroid carcinoma: what is being treated?131I治疗分化型甲状腺癌中131I全身扫描阴性但甲状腺球蛋白阳性的情况：治疗的是什么？

Thyroid. 1997 Aug;7(4):669-72. doi: 10.1089/thy.1997.7.669.

Evaluation of radioiodine therapy in differentiated thyroid cancer subjects with elevated serum thyroglobulin and negative whole body scan using 131I with emphasize on the thallium scintigraphy in these subgroups.评估血清甲状腺球蛋白升高且全身 131I 扫描阴性的分化型甲状腺癌患者的放射性碘治疗效果，强调这些亚组中的铊闪烁显像。

Eur Rev Med Pharmacol Sci. 2011 Oct;15(10):1215-21.

Treatment of scan-negative, thyroglobulin-positive metastatic thyroid cancer using radioiodine 131I and recombinant human thyroid stimulating hormone.

J Clin Endocrinol Metab. 1997 Jan;82(1):11-4. doi: 10.1210/jcem.82.1.3696.

Treatment of iodine negative, thyroglobulin positive, thyroid cancer patients: do we miss the target when we shoot in the dark?碘阴性、甲状腺球蛋白阳性的甲状腺癌患者的治疗：我们在黑暗中射击时是否会错失目标？

Nucl Med Commun. 2003 Jul;24(7):739-41. doi: 10.1097/00006231-200307000-00001.

Is empiric 131I therapy justified for patients with positive thyroglobulin and negative 131I whole-body scanning results?对于甲状腺球蛋白阳性而131I全身扫描结果阴性的患者，经验性131I治疗是否合理？

J Nucl Med. 2005 Jul;46(7):1164-70.

Management of differentiated thyroid cancer with rising thyroglobulin and negative diagnostic radioiodine whole body scan.分化型甲状腺癌伴甲状腺球蛋白升高及阴性诊断性放射性碘全身扫描的处理。

Clin Oncol (R Coll Radiol). 2010 Aug;22(6):438-47. doi: 10.1016/j.clon.2010.05.005. Epub 2010 Jun 18.

99mTc-sestamibi and 131I whole-body scintigraphy and initial serum thyroglobulin in the management of differentiated thyroid carcinoma.99m锝-甲氧基异丁基异腈和131碘全身闪烁扫描及初始血清甲状腺球蛋白在分化型甲状腺癌治疗中的应用

J Nucl Med. 2000 Apr;41(4):631-5.

引用本文的文献

Long-term course and predictive factors of elevated serum thyroglobulin and negative diagnostic radioiodine whole body scan in differentiated thyroid cancer.分化型甲状腺癌患者血清甲状腺球蛋白升高且诊断性放射性碘全身扫描阴性的长期病程及预测因素

J Endocrinol Invest. 2005 Jun;28(6):540-6. doi: 10.1007/BF03347243.

Preoperative neck ultrasonographic mapping for persistent/recurrent papillary thyroid cancer.

World J Surg. 2004 Nov;28(11):1110-4. doi: 10.1007/s00268-004-7636-5.

本文引用的文献

Staging in thyroid carcinoma.甲状腺癌的分期

Cancer. 1998 Sep 1;83(5):844-7. doi: 10.1002/(sici)1097-0142(19980901)83:5<844::aid-cncr6>3.0.co;2-i.

Treatment of micronodular lung metastases of papillary thyroid cancer: are the tumors too small for effective irradiation from radioiodine?甲状腺乳头状癌微小结节性肺转移的治疗：这些肿瘤是否太小以至于无法通过放射性碘进行有效照射？

Thyroid. 1998 Mar;8(3):215-21. doi: 10.1089/thy.1998.8.215.

Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma.重组人促甲状腺素给药与甲状腺激素撤减用于甲状腺癌患者放射性碘扫描的比较。

N Engl J Med. 1997 Sep 25;337(13):888-96. doi: 10.1056/NEJM199709253371304.

74 MBq radioiodine 131I does not prevent uptake of therapeutic doses of 131I (i.e. it does not cause stunning) in differentiated thyroid cancer.74 兆贝可的放射性碘 131I 不会阻止分化型甲状腺癌对治疗剂量的 131I 的摄取（即它不会导致摄取障碍）。

Nucl Med Commun. 1997 Jun;18(6):505-12. doi: 10.1097/00006231-199706000-00002.

131I therapy for elevated thyroglobulin levels.

Thyroid. 1997 Apr;7(2):273-6. doi: 10.1089/thy.1997.7.273.

Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989.预测甲状腺乳头状癌的预后：在1940年至1989年间于一家机构接受手术治疗的1779例患者队列中开发一种可靠的预后评分系统。

Surgery. 1993 Dec;114(6):1050-7; discussion 1057-8.

Influence of diagnostic radioiodines on the uptake of ablative dose of iodine-131.诊断性放射性碘对碘-131消融剂量摄取的影响。

Thyroid. 1994 Spring;4(1):49-54. doi: 10.1089/thy.1994.4.49.

Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.初始手术和药物治疗对乳头状和滤泡状甲状腺癌的长期影响。

Am J Med. 1994 Nov;97(5):418-28. doi: 10.1016/0002-9343(94)90321-2.

Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan.碘-131治疗甲状腺球蛋白升高且诊断性扫描阴性的甲状腺癌患者。

J Clin Endocrinol Metab. 1995 May;80(5):1488-92. doi: 10.1210/jcem.80.5.7744991.

Follow-up of patients with differentiated thyroid cancer using serum thyroglobulin measured by an immunoradiometric assay. Comparison with I-131 total body scans.采用免疫放射分析测定血清甲状腺球蛋白对分化型甲状腺癌患者进行随访。与I-131全身扫描的比较。

J Nucl Med. 1980 Aug;21(8):741-4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验